Redesign Health: A Health-focused Venture Firm Seeking $250 Million to Support its Portfolio Companies

Redesign Health, a health-focused venture firm and startup studio based in New York, is currently seeking to raise $250 million. This fundraising effort comes after the company’s successful previous efforts, including a $250 million raise in March 2021 and a $65 million Series C funding round in September 2022.

Redesign Health has developed and launched over 65 healthtech companies since its establishment in 2018. Its unique model combines aspects of a venture capital firm with a startup incubator, resulting in successful ventures such as home health provider MedArrive and weight-loss startup Calibrate.

The details of how the new $250 million raise would be utilized are not yet clear, as the fundraising efforts are ongoing and terms could change. However, it is clear that Redesign Health remains committed to supporting its portfolio companies moving forward, despite recent challenges faced by some of its well-funded companies.

Calibrate, for example, encountered difficulties last year with cash burn and customer complaints related to access to weight-loss drugs. Despite these challenges, Redesign Health has remained dedicated to supporting its portfolio companies and helping them navigate the evolving fundraising landscape.

Despite recent challenges, Redesign Health’s post-money valuation reached $1.7 billion following a series of funding rounds and workforce adjustments. The company is focused on continuing to support its portfolio companies while navigating the evolving fundraising landscape.